Consolidated Figures in USD Millions.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Total Revenue | - | 903.50 | 1,051.83 | 1,071.64 | 965.66 |
| Operating Revenue | - | 903.50 | 1,051.83 | 1,071.64 | 965.66 |
| Cost Of Revenue | - | 249.49 | 307.83 | 318.83 | 281.52 |
| Gross Profit | - | 654.01 | 744 | 752.81 | 684.14 |
| Operating Expense | - | 611.47 | 690.62 | 551.70 | 443.67 |
| Research And Development | - | 109.02 | 130.56 | 100.72 | 121.51 |
| Selling General And Administration | - | 412.74 | 492.03 | 380.36 | 296.30 |
| Total Expenses | - | 860.96 | 998.46 | 870.53 | 725.18 |
| Operating Income | - | 42.54 | 53.37 | 201.11 | 240.48 |
| Total Operating Income As Reported | - | -102.84 | 53.37 | -700.47 | -805.78 |
| EBITDA | - | 3.06 | 94.86 | -634.68 | -792.67 |
| Normalized EBITDA | - | 148.45 | 94.86 | 266.90 | 253.58 |
| EBIT | - | -86.66 | 26.84 | -705.30 | -818.53 |
| Interest Expense | - | 24.06 | 21.53 | 39.94 | 42.45 |
| Net Interest Income | - | -24.06 | -21.53 | -39.94 | -42.45 |
| Other Non Operating Income Expenses | - | 16.19 | -26.54 | -4.83 | -12.75 |
| Other Income Expense | - | -129.20 | -26.54 | -906.41 | -1,059.01 |
| Interest Expense Non Operating | - | 24.06 | 21.53 | 39.94 | 42.45 |
| Net Non Operating Interest Income Expense | - | -24.06 | -21.53 | -39.94 | -42.45 |
| Pretax Income | - | -110.72 | 5.30 | -745.25 | -860.98 |
| Tax Provision | - | 3.41 | 7.17 | 23.13 | 34.37 |
| Tax Rate For Calcs | - | 0 | 0 | 0 | 0 |
| Tax Effect Of Unusual Items | - | -30.53 | 0 | -189.33 | -219.71 |
| Net Income Continuous Operations | - | -114.12 | -1.87 | -768.37 | -895.34 |
| Net Income From Continuing And Discontinued Operation | - | -79.75 | -4.21 | -557.01 | -693.14 |
| Net Income From Continuing Operation Net Minority Interest | - | -79.75 | -4.21 | -557.01 | -693.14 |
| Net Income | - | -79.75 | -4.21 | -557.01 | -693.14 |
| Net Income Common Stockholders | - | -79.69 | -4.29 | -557.27 | -655.51 |
| Net Income Including Noncontrolling Interests | - | -114.12 | -1.87 | -768.37 | -895.34 |
| Normalized Income | - | 35.11 | -4.21 | 155.24 | 133.40 |
| Diluted NI Availto Com Stockholders | - | -79.69 | -4.32 | -557.27 | -655.51 |
| Basic Average Shares | - | 128.62 | 140.43 | 120.82 | 110.13 |
| Diluted Average Shares | - | 128.62 | 140.43 | 120.82 | 110.13 |
| Reconciled Depreciation | - | 89.71 | 68.03 | 70.62 | 25.86 |
| Reconciled Cost Of Revenue | - | 249.49 | 307.83 | 318.83 | 281.52 |
| Total Unusual Items | - | -145.39 | 0 | -901.59 | -1,046.26 |
| Total Unusual Items Excluding Goodwill | - | -145.39 | 0 | -901.59 | -1,046.26 |
| Minority Interests | - | 34.38 | -2.35 | 211.37 | 202.21 |
| Special Income Charges | - | -145.39 | 0 | -901.59 | -1,046.26 |
| Impairment Of Capital Assets | - | 145.39 | 0 | 892.25 | 1,039.03 |
| Restructuring And Mergern Acquisition | - | - | - | 9.34 | 7.23 |
| Depreciation Amortization Depletion Income Statement | - | 89.71 | 68.03 | 70.62 | 25.86 |
| Depreciation And Amortization In Income Statement | - | 89.71 | 68.03 | 70.62 | 25.86 |
| General And Administrative Expense | - | 163.47 | 221.65 | 122.43 | 133.33 |
| Other Gand A | - | 163.47 | 221.65 | 122.43 | 133.33 |
| Total Other Finance Cost | 24.57 | 24.06 | 21.53 | - | - |
| Selling And Marketing Expense | - | 249.27 | 270.38 | 257.93 | 162.97 |
| Otherunder Preferred Stock Dividend | - | -0.06 | 0.07 | 0.26 | -37.63 |
| Average Dilution Earnings | 98.36 | 0 | -0.03 | 0 | - |
